Atuveciclib S-Enantiomer
Atuveciclib S-Enantiomer (BAY-1143572 S-Enantiomer) is the (S)-enantiomer of BAY-1143572. Atuveciclib S-Enantiomer is a potent and selective CDK9 inhibitor, which inhibits CDK9 / CycT1 with an IC 50 of 16 nM.
Atuveciclib (BAY-1143572) S-Enantiomer reveals very similar in vitro properties compared with Atuveciclib (BAY-1143572), well within the limits of measurement accuracy. However, with multiple batches of Atuveciclib (BAY-1143572) S-Enantiomer, there is a trend toward a slightly lower activity against CDK9 in the biochemical assay (IC 50 CDK9/CycT1: 16 nM) and antiproliferative activity against HeLa cells (IC 50 : 1100 nM) [1].
Atuveciclib (BAY-1143572) S-Enantiomer shows blood/plasma ratios of about 1. Relative to Atuveciclib (BAY-1143572), Atuveciclib (BAY-1143572) S-Enantiomer reveals very similar rat PK properties in vivo (CL b : 1.2 L/kg per hour, V ss : 1.2 L/kg, t 1/2 : 0.6 h, F: 53 %) [1].
250279-81-1
C18H18FN5O2S
387.43
BAY-1143572 S-Enantiomer;Atuveciclib S-Enantiomer
储存和溶解度
DMSO:113 mg/mL (291.67 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
本产品只适用于科研,不能用于临床诊断。严禁用于临床医疗及其他非科研用途!
以实际收货产品说明书为准,网站说明书仅供参考。